On (b)(6) 2017, the vigilance department received a report from a pharmacy personnel that a patient experienced tingling after using the contact lenses.It was indicated that a multipurpose lens care solution was used to clean the contact lenses.It was reported that the patient visited an ophthalmologist the following day as the symptoms have aggravated, unknown if treatments were provided.The patient was reportedly hospitalized on (b)(6) 2017 due to no improvement on the patient's symptoms.The reported clinical consequences were pseudomonas abscess under the left eye, endophthalmitis, and decreased visual acuity.Further information received on 10/23/2017 via a completed questionnaire by a pharmacy intern stated that this complaint is in reference to a (b)(6) -year-old male patient.The patient had been reportedly hospitalized from (b)(6) 2017 and underwent surgical intervention (not specified but reported as a "probable" first amniotic graft membrane) on (b)(6) 2017.It was noted that cultures were taken and were positive to enterobacter cloacae, raoultella planticola, and pseudomonas aeruginosa.It was further stated that on (b)(6) 2017, the patient underwent a second amniotic membrane graft on the left eye in a context of a pseudomonas corneal abscess.Technical and procedure of the intervention include the following: debridement of the operating site; hand washing with soft soap and hydro alcoholic solution; surgery gloves; betadine disinfection in the eyelids, ciliary edge and conjunctival culs-de-sacs; operating drape to incise stuck, opened eyelids; installation of surgical microscope decontaminated with ultraviolet and steril lens filter; positioning of first and second layers of amniotic membrane graft hold by peri limbic vicryl 8.0 seam in conjunctive; shell and dressing.It was indicated that the patient was prescribed with ceftazidime eye drop one drop eight times daily, amikacin eye drop one drop eight times daily, and atropine 1% one drop three times daily.It was reported that the event had resolved with treatment.No additional information has been received.
|